New York, NY - January 29, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented 60 Degrees Pharmaceuticals, Inc. (Nasdaq: SXTP; SXTPW), a pharmaceutical company focused on developing …
Sichenzia Ross Ference Carmel LLP Represents Virpax Pharmaceuticals in $6 Million Public Offering
New York, NY - January 28, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a preclinical-stage pharmaceutical company focused in …
Sichenzia Ross Ference Carmel LLP Represents A.G.P/Alliance Global Partners in the $60 Million Initial Public Offering of Columbus Acquisition Corp
Press Release – New York, NY – January 24, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented A.G.P/Alliance Global Partners in the $60 million initial public offering …
Sichenzia Ross Ference Carmel LLP Represents PMGC Holdings Inc. in $1.9 Million Warrant Inducement
New York, NY - January 27, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented PMGC Holdings Inc. (formerly Elevai Labs Inc.), a diversified holding company, in its $1.9 million …
Sichenzia Ross Ference Carmel LLP Represents Dominari Securities and Revere Securities in $6 Million Initial Public Offering of Skyline Builders Group Holdings Limited
New York, NY - January 23, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented Dominari Securities LLC and Revere Securities LLC as the underwriters in the $6 million initial public …
Sichenzia Ross Ference Carmel LLP Represents Cyngn Inc. in Financing Transactions Aggregating $33 Million in Gross Proceeds
Press Release - New York, NY - January 23, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented Cyngn Inc. (the “Company”) in a $20.0 million follow-on offering of common stock units …
